23and me stock.

Shares of 23andMe Holding ( ME 3.64%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...

23and me stock. Things To Know About 23and me stock.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.23andMe Holding Co. Watch list NEW Set a price target alert Open Last Updated: Nov 30, 2023 1:01 p.m. EST Real time quote $ 0.8865 -0.0091 -1.02% Previous Close $0.8956 Advanced Charting Volume:... 23andMe Holding Co. ( ME) has fallen Thursday morning, with the stock losing -1.80% in pre-market trading to 1.64. ME's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market. In the Diagnostics & Research industry, which ranks 124 out of 146 industries, 23andMe ...What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75.

Power to Investors. A high-level overview of 23andMe Holding Co. (ME) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, …The 23andMe on Monday confirmed hackers stole personal data from approximately 6.9 million users. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images/File / Getty Images ...

Shares of 23andMe Holding ( ME 2.88%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...

Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition is expected to close by the end of 2021. The acquisition adds Lemonaid Health’s innovative telemedicine and …ME Earnings Date and Information. 23andMe last announced its earnings results on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to analyst estimates of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) diluted earnings per ...1.9200. 1.9400. 1.9400. 1,700,200. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for ME stock on Yahoo Finance. View daily, weekly or monthly format back to when 23andMe Holding Co. stock was issued.4 de fev. de 2021 ... VGAC IS MERGING with 23andMe | Warrants explained | BUY? 60K views · 2 years ago #VGAC #WARRANTS #CCIV ...more. STOCK UP! with LARRY JONES. 614K.

Hackers stole personal data belonging to 6.9 million people who used services from the genetic testing company 23andMe in October, a company spokesperson …

23andMe Holding Co Class A ME Stock XNAS Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance …

Find the latest Earnings Report Date for 23andMe Holding Co. Class A Common Stock (ME) at Nasdaq.com.6 de set. de 2023 ... 23andMe Holding Co. (ME) stock is down -66.15% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.See the company profile for 23andMe Holding Co. (ME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ... Aug 13, 2021 · FY2022 First Quarter Financial Results. Total revenue was $59 million for the quarter ended June 30, 2021, representing an increase of $11 million or 23%, year over year. This revenue growth was primarily due to higher Personal Genome Service (PGS) kit sales, which resulted from increased marketing spending and growth in consumer demand. All Those 23andMe Spit Tests Were Part of a Bigger Plan. CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone ...

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Stock price history for 23andMe (ME) Highest end of day price: $17.65 USD on 2021-02-04. Lowest end of day price: $0.71 USD on 2023-11-09. Stock price history of 23andMe from 2020 to 2023. What is the market capitalization of a company?Full-year revenue guidance of $260-280 million was reiterated, but adjusted EBITDA loss guidance of $195-215 million remains disappointing. With the company's enterprise value now under $1 billion ...ME. +10.27%. DNA-testing company 23andMe confirmed Monday that information about 6.9 million people, about half of its 14 million customers, was accessed illegally. feature had their Family Tree ...Feb 9, 2021 · Once VGAC's shareholders vote to consent to the deal, the shell company will be delisted and 23andMe will trade on the New York Stock Exchange (NYSE) under the ticker ME. Per the terms of the ... Sep 27, 2022 · Full-year revenue guidance of $260-280 million was reiterated, but adjusted EBITDA loss guidance of $195-215 million remains disappointing. With the company's enterprise value now under $1 billion ... 23andMe says only 0.1% of user accounts affected in data breach. 23andMe Holding ( NASDAQ: ME) traded higher on Monday after announcing in a regulatory filing that hackers accessed only 0.1% of ...

Jan 18, 2022 · This decision also allows 23andMe to strategically invest capital and resources into advancing our diverse portfolio of therapeutic programs.” 23andMe’s Therapeutics team was established in 2015 with the goal to improve the way drug discovery is currently conducted by starting with human genetic information.

27.55%. Get the latest 23andMe Holding Co. (ME) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Hackers stole personal data belonging to 6.9 million people who used services from the genetic testing company 23andMe in October, a company …On June 17, 23andMe, which pioneered personalized medicine and at-home genetic testing kits 15 years ago, went public through a merger with a Richard Branson SPAC under the ME ticker and saw its ...23andMe Holding Co. is a publicly held personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic ...To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios. Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on. 23andMe Holding Co. has a Value Score of 51, which is Average.The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion ; 23andMe CEO and Co-Founder Anne Wojcicki and Virgin Group’s Sir Richard Branson are each investing $25 million into the $250 million PIPE and are joined by leading institutional investors …

On Friday, genetic testing company 23andMe announced that hackers accessed the personal data of 0.1% of customers, or about 14,000 individuals. The …

Find out the direct holders, institutional holders and mutual fund holders for 23andMe Holding Co. (ME).

ME. +6.60%. Shares of 23andMe Holding Co. ME rallied more than 12% in the extended session Wednesday after the genetics company raised guidance for 2023. 23andMe lost $92 million, or 20 cents a ...Consumer-Driven Healthcare Data Finance Genomics. 23andMe is merging with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, to go public. The deal ...Stock analysis for 23andMe Holding Co (ME:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.View 23andMe Holding Co ME investment & stock information. Get the latest 23andMe Holding Co ME detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.23andMe to Report FY2024 Second Quarter Financial Results. SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report ...May 1, 2023 at 11:54 AM · 2 min read. 23andMe co-founder and CEO Anne Wojcicki sees a much bigger presence for her DNA decoding company in the pharma space. "The end of the GSK collaboration ...FY2022 First Quarter Financial Results. Total revenue was $59 million for the quarter ended June 30, 2021, representing an increase of $11 million or 23%, year over year. This revenue growth was primarily due to higher Personal Genome Service (PGS) kit sales, which resulted from increased marketing spending and growth in consumer demand.The 23andMe on Monday confirmed hackers stole personal data from approximately 6.9 million users. (Photo Illustration by Pavlo Gonchar/SOPA …23andMe shares surge 21% in their trading debut after merger with Richard Branson-backed SPAC Last Updated: June 19, 2021 at 1:17 p.m. ET First Published: June 17, 2021 at 2:14 p.m. ETA. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ...Shares of 23andMe Holding ( ME 2.88%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...ME. +11.44%. Shares of 23andMe Holding Co. were falling more than 7% in premarket trading Friday after the DNA-testing company disclosed that Chief Financial Officer Stevem Schoch was resigning ...

23andMe Holding Co. (ME) Stock Price & News - Google Finance Markets Dow Futures $35,365.00 -0.023% -$8.00 S&P Futures -0.16% -$7.50 -0.19% -$31.00 Gold $2,042.50 +0.47% +$9.50 Crude Oil $75.65... See the company profile for 23andMe Holding Co. (ME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17. SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin …Instagram:https://instagram. nice ltd.heqtviti stockbest coinbase alternative Anne Wojcicki is the CEO and Co-Founder of 23andMe. She co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent … otcmkts crlbfbest stock chart A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ... salem.media group Dec 4, 2023 11:59 AM PST. By Jon Swartz. Company says it believes breach was the result of customers recycling passwords. DNA-testing company 23andMe confirmed Monday that information about 6.9 ...23andMe Holding Co. Class A Common Stock (ME) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Nov 21, 2022 · 23andMe Holding Co. ( NASDAQ: ME) is a genomics research company that aims to make genetic testing commonplace and mainstream. The global genomics industry was valued at $27.81 billion in 2021 and ...